http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9723619-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d56fd7a472cd84088423278152786768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_857f8336175d4a3144facf2e9ad3998b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0668144e351348222c555814f08a7c6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c14f49466949ac32adc53f9ae8ded8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_818f0ca6b3f30667753384d06d278852 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-335 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-335 |
| filingDate | 1996-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c26acfcaaee3d8b212221a5a443949a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aa55fd9b81d18eb2f79eaa93af70a61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c595d3eb70775a415f48869218edc535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35233bd26416ab8acb6032c91ac2cf47 |
| publicationDate | 1997-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9723619-A1 |
| titleOfInvention | Sequences coding for new bacteriocins |
| abstract | The present invention relates to novel sequences encoding a novel bacteriocin, the uses thereof, as well as the use of sequences for homologous and heterologous protein expression and secretion purposes. The present invention relates more particularly to a polynucleic acid comprising: (a) at least 30 contiguous nucleotides of a sequence selected from the polynucleic acid sequence as shown in Figure 2 (SEQ ID NO: 19), (b) a polynucleic acid sequence which hybridizes to the polynucleic acid as defined in (a), or (c) a polynucleic acid with a sequence that is degenerated to a polynucleic acid as defined in (a) or (b) as a result of the genetic code. The polynucleic acid sequence represented as SEQ ID NO: 19 in Figure 2 comprises five operons (see Figure 3). The first two are composed of three open reading frames: two 'bacteriocin-like' genes, followed by an 'immunity gene'. The third operon is composed of two open reading frames, the first is coding for an ATP-dependent transporter protein, the second is coding for an accessory protein. The fourth operon is composed of two open reading frames, one 'bacteriocin-like' gene followed by an 'immunity gene'. The fifht operon is composed of three open reading frames: two 'bacteriocin-like' genes, followed by an 'immunity gene'. Each operon is preced by a promoter. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247306-B2 |
| priorityDate | 1995-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.